Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2
Described herein is the design and synthesis of indazolylaminopyridopyrimidines and quinazolines as inhibitors of the class 1 tyrosine kinase receptor family. Data is presented for N4-(1-benzyl-1H-indazol-5-yl)-N6,N6- dime